Select Medical (NYSE:SEM) Upgraded at StockNews.com

Select Medical (NYSE:SEM) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

A number of other equities research analysts have also recently commented on the stock. Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. UBS Group lowered their target price on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Finally, Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.

Select Medical Price Performance

Select Medical stock opened at $19.11 on Friday. The stock has a market cap of $2.47 billion, a P/E ratio of 8.93, a P/E/G ratio of 0.64 and a beta of 1.45. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company’s 50 day moving average price is $19.13 and its two-hundred day moving average price is $28.07. Select Medical has a 52 week low of $18.02 and a 52 week high of $40.98.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a net margin of 3.97% and a return on equity of 15.99%. On average, equities analysts predict that Select Medical will post 1.97 earnings per share for the current year.

Insider Transactions at Select Medical

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Hedge Funds Weigh In On Select Medical

Institutional investors have recently added to or reduced their stakes in the business. KBC Group NV grew its holdings in shares of Select Medical by 4.5% during the third quarter. KBC Group NV now owns 13,050 shares of the health services provider’s stock worth $455,000 after purchasing an additional 563 shares in the last quarter. LPL Financial LLC lifted its position in Select Medical by 2.0% during the fourth quarter. LPL Financial LLC now owns 31,441 shares of the health services provider’s stock valued at $593,000 after purchasing an additional 619 shares during the last quarter. Swiss National Bank grew its stake in Select Medical by 0.4% in the 3rd quarter. Swiss National Bank now owns 215,900 shares of the health services provider’s stock worth $7,528,000 after buying an additional 800 shares in the last quarter. Quarry LP bought a new position in shares of Select Medical in the 3rd quarter worth $30,000. Finally, Bank of Montreal Can raised its position in shares of Select Medical by 4.5% during the 4th quarter. Bank of Montreal Can now owns 20,030 shares of the health services provider’s stock valued at $378,000 after buying an additional 867 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.